跳至主要内容
临床试验/NCT04918394
NCT04918394已完成不适用

Assessment of Mold Exposure in Asthmatic Children Follow-up in Nord and Pas-De-Calais Departments, France, and Impact on Asthma Control

University Hospital, Lille10 个研究点 分布在 1 个国家目标入组 451 人开始时间: 2020年6月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
451
试验地点
10
主要终点
Asthma control according to GINA guidelines

研究概览

简要总结

Observational, multicenter, study conducted in 12 hospitals in the Nord and Pas-De-Calais departments. The aim of this study is to describe the relationship between reported exposure to molds and asthma control in a pediatric population.

Each patient followed by a specialized asthma pediatrician in one of the study center will be proposed to participate in the study.

Children aged 1 to < 18 years, with asthma diagnosis, based on the assessment of a specialized physician after a follow-up of at least 6 months Inclusion, non-inclusion and exclusion criteria will be verified by the investigators. The questionnaires will be completed during the consultation, collected by the physician in charge of the consultation and sent to the principal investigator for data entry.

Inclusion will take place over a period of 12 consecutive months from the date of obtaining regulatory approval.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Year 至 18 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Children aged 1 to < 18 years, with asthma diagnosis, based on the assessment of a specialized physician after a follow-up of at least 6 months, Follow-up in one of the study center in Nord and Pas de Calais departments (Lille, Lens, Tourcoing, Valenciennes, Arras, Roubaix, Seclin, Armentières, Calais, Boulogne/mer, Dunkerque, GHICL-Saint Vincent) over an inclusion period of 12 months

排除标准

  • •Children living ≤ 50% of the weekly time in their primary home (e.g., shared custody)
  • •Children whose living arrangement characteristics are difficult to analyze (e.g., child accompanied by grandparents or by the parent without primary custody)
  • •Children whose residence has recently changed, making it impossible to assess the impact of the living arrangement over the past year
  • •Children living outside of the Nord and Pas-de-Calais departments
  • •Children whose parents are unable to complete the questionnaire

研究组 & 干预措施

Asthma patients unexposed to mold / moisture

No mold / moisture exposure is defined by a negative response to all of the 5 following questions, asked in the form of a parent-completed declarative questionnaire regarding the child's primary living home.

干预措施: Questionnaire of Mold / moisture exposure (Other)

Asthma patients exposed to mold / moisture

Mold / moisture exposure is defined by a positive response to at least one of the 5 following questions, asked in the form of a parent-completed declarative questionnaire regarding the child's primary living home.

干预措施: Questionnaire of Mold / moisture exposure (Other)

结局指标

主要结局

Asthma control according to GINA guidelines

时间窗: At the time of inclusion

The Global Initiative for Asthma (GINA)guidelines: Well controlled Partly controlled Uncontrolled

次要结局

  • Acute asthma events in the past 12 months(At the time of inclusion)
  • Inhaled corticosteroid doses in µg/day of fluticasone(At the time of inclusion)
  • Exposure to indoor allergens: declarative exposure to house dust mite (carpet, mattress)(At the time of inclusion)
  • Asthma control according to Asthma Control Test (ACT) score in children aged 12 years and older: Controlled if ACT ≥ 20(At the time of inclusion)
  • Exposure to indoor allergens: declarative exposure to animal danders(At the time of inclusion)
  • Asthma control according to pACT score in children aged 1 to 11 years old: Controlled if ACT ≥ 20(At the time of inclusion)
  • Exposure to other indoor pollutants: cigarette smoke (declarative smoking by at least one of the parents)(At the time of inclusion)
  • Asthma treatment step according to GINA guidelines: Step 1 to step 4 in children aged < 6 years Step 1 to step 5 in children aged ≥ 6 years(At the time of inclusion)

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验